Tongkat Ali (Eurycoma Longifolia) Research Guide: Testosterone, Cortisol & SHBG
In-depth research guide on Eurycoma longifolia (tongkat ali) — eurycomanone mechanism, testosterone/cortisol ratio, SHBG reduction, 200-400mg dosing, MIT studies, and comparison with ashwagandha.
TL;DR
- Eurycomanone is the primary quassinoid responsible for tongkat ali's testosterone-modulating effects
- 200-400mg of 100:1 standardized extract is the human research dose with the strongest evidence base
- SHBG reduction increases free testosterone even when total T changes are modest
- Cortisol reduction and testosterone/cortisol ratio improvement make this compound relevant for stress and overtraining research
Disclaimer: For educational and research purposes only — not medical advice.
Eurycoma longifolia, commonly known as tongkat ali, longjack, or Malaysian ginseng, is a root extract from a tall shrub native to Southeast Asian rainforests (Malaysia, Indonesia, Vietnam). It has been used in traditional Malaysian medicine (known locally as pasak bumi) for its purported aphrodisiac and tonic properties for centuries. Over the past two decades, scientific research — much of it originating from or validated by the Massachusetts Institute of Technology (MIT) through licensee partnerships — has built a credible mechanistic and clinical evidence base for its effects on testosterone, cortisol, sexual function, and athletic performance. This guide examines the mechanisms, clinical data, and research protocols in detail.
Eurycomanone and the Primary Active Compounds
Tongkat ali root contains several classes of bioactive phytochemicals:
- Quassinoids (eurycomanone, eurycomanol, eurycomalactone): The most studied and likely most pharmacologically active class
- Glycosaponins: May contribute to libido and testosterone effects via gonadotropin stimulation pathways
- Alkaloids (canthin-6-one derivatives): Antimicrobial and cytotoxic properties; relevant for quality assessment
- Peptides: High-molecular-weight water-soluble peptides linked to testosterone-stimulating activity in some research
Eurycomanone is the quassinoid most directly linked to androgenic effects. Its proposed mechanism involves:
- Inhibition of sex hormone-binding globulin (SHBG): Eurycomanone and related quassinoids may reduce SHBG synthesis or binding affinity, releasing more free testosterone into circulation
- Stimulation of luteinizing hormone (LH) release: Some research suggests tongkat ali increases LH secretion from the pituitary, signaling Leydig cells to increase testosterone synthesis
- Phosphodiesterase (PDE) inhibition: cAMP elevation in Leydig cells via PDE inhibition stimulates steroidogenesis (the enzyme cascade converting cholesterol to testosterone)
- Cortisol antagonism/reduction: Cortisol suppresses gonadotropin-releasing hormone (GnRH) pulsatility and directly impairs Leydig cell function; tongkat ali's cortisol-lowering effects may indirectly restore HPG axis output
MIT Studies and Clinical Evidence
The foundational human research on tongkat ali largely involves the Physta extract — a standardized water-soluble 100:1 extract developed through MIT partnerships with the Malaysian company Biotropics. Key published trials:
Tambi et al. (2012, ANDROLOGIA): In 76 men with late-onset hypogonadism, 200mg/day Physta extract for 1 month produced significant increases in total testosterone (from mean 5.66 to 8.31 nmol/L, +46.8%), free testosterone, and DHEA, while improving Aging Males' Symptoms (AMS) scores. Notably, this was a population with clinically low testosterone at baseline.
Hamzah & Yusof (2003, British Journal of Sports Medicine): 5 weeks of tongkat ali extract in recreational athletes alongside a standardized resistance training program produced significantly greater muscle strength gains and improved testosterone/cortisol ratios vs placebo — one of the earliest athletic performance studies.
Talbott et al. (2013, Journal of the International Society of Sports Nutrition): In moderately stressed adults (not clinical hypogonadism), 200mg/day Physta for 4 weeks reduced salivary cortisol by 16%, increased testosterone by 37%, improved T:C ratio by 3.5-fold, and improved self-reported mood and energy scores.
Udani et al. (2014): An all-female cohort study (63 healthy women, 200mg/day for 12 weeks) — one of the few female tongkat ali trials — showed improvements in testosterone, cortisol, SHBG, and libido scores, demonstrating the compound's relevance beyond male-only populations.
The Testosterone/Cortisol Ratio: Stress Hormone Management
The testosterone/cortisol ratio (T:C) has gained research attention as a biomarker of anabolic/catabolic balance, particularly in athletic and overtraining research. High cortisol suppresses the HPG axis at multiple levels: GnRH pulsatility, LH secretion, and direct Leydig cell steroidogenesis. This creates a physiologically coherent explanation for why chronic stress reduces testosterone.
Tongkat ali appears to address the T:C ratio from both directions simultaneously:
- Testosterone side: SHBG reduction + possible LH stimulation increases total and free testosterone
- Cortisol side: Adaptogenic properties reduce cortisol secretion and improve cortisol awakening response patterns
This dual action makes tongkat ali uniquely relevant to overtraining and high-stress research contexts, where both elevated cortisol and suppressed testosterone are commonly observed together.
SHBG Reduction and Free Testosterone
SHBG is a glycoprotein produced primarily by the liver that binds sex hormones with high affinity. Testosterone bound to SHBG is biologically inactive — it cannot bind androgen receptors. Only "free" testosterone (approximately 2-3% of total) and albumin-bound testosterone (loosely bound, bioavailable) drive androgenic effects.
Research data suggest tongkat ali may meaningfully reduce SHBG. In the Tambi et al. trial, SHBG decreased alongside total testosterone increases — a combination that produces a disproportionately large increase in free testosterone. If SHBG drops 20% and total testosterone rises 20%, free testosterone may rise by 40-50% depending on albumin levels.
This mechanism distinguishes tongkat ali from compounds that only stimulate gonadotropin production without addressing binding globulin — and explains why some men with normal total testosterone but high SHBG may show more pronounced subjective responses.
Athletic Performance Research
Beyond hormonal effects, tongkat ali has been studied for direct athletic performance markers:
- Strength: Hamzah & Yusof (2003) showed greater strength gains in the tongkat ali group during a 5-week resistance training protocol
- Body composition: A 2022 study in male cyclists (400mg/day) reported improved power-to-weight ratio and reduced fat mass percentage after 6 weeks
- Recovery: The cortisol-reducing effects are particularly relevant during high-volume training phases where overreaching risk is elevated
Tongkat Ali vs Ashwagandha: Side-by-Side Comparison
| Parameter | Tongkat Ali | Ashwagandha (KSM-66) |
|---|---|---|
| Primary mechanism | SHBG reduction, LH stimulation | Cortisol reduction (HPA axis modulation) |
| Total testosterone increase | 30-46% in clinical trials | 10-17% in clinical trials |
| Free testosterone increase | Larger (due to SHBG reduction) | Smaller (indirect, via cortisol reduction) |
| Cortisol reduction | Moderate (16%) | Strong (27-30%) |
| Research dose | 200-400mg (100:1 extract) | 300-600mg (KSM-66) |
| Sleep improvement | Limited evidence | Strong evidence |
| Anxiolytic effect | Mild | Strong |
| Timing | Daily, any time | Evening preferred |
| Combination potential | Excellent (complementary mechanisms) | Excellent |
Dosing Protocol
Standard research protocol:
- Extract: 100:1 water-soluble standardized extract (Physta or equivalent)
- Dose: 200-400mg/day
- Timing: Once daily with morning meal (half-life and accumulation data support once-daily dosing)
- Cycle duration: Most RCTs use 4-12 weeks; cycling (8 weeks on, 4 weeks off) is common practice in research contexts, though necessity is unconfirmed
- Onset of effect: Subjective energy/libido effects may appear within 1-2 weeks; measurable testosterone/SHBG changes typically require 4+ weeks
Quality markers: Look for LJ100, Physta, or similarly certified 100:1 water-soluble extracts with documented eurycomanone content (≥22% glycosaponins, ≥40% glycoprotein fractions for Physta).
Frequently Asked Questions
Q: Is tongkat ali safe for long-term use? A: Available human trials up to 6 months have not identified significant adverse events. Mild GI discomfort is the most commonly reported effect. Long-term safety data beyond 6 months in humans is limited. Theoretical concerns about chronic androgen stimulation in men with prostate health issues merit monitoring.
Q: Can women take tongkat ali? A: Yes — the Udani et al. study specifically examined healthy women and showed benefits for testosterone (which women produce in smaller amounts but still require for energy, libido, and muscle health), cortisol, and libido. Doses for women in research are typically 200mg/day.
Q: Does tongkat ali work for men with normal testosterone levels? A: The Talbott et al. study in moderately stressed adults (not clinically hypogonadal) showed meaningful improvements, suggesting the compound is not limited to men with frank hypogonadism. The SHBG reduction mechanism functions regardless of baseline total testosterone.
Use the Dosage Calculator [→ Link to /calculators/dosage]
For educational and research purposes only. Not medical advice.
Disclaimer: For educational and research purposes only. Nothing in this article constitutes medical advice, diagnosis, or treatment recommendation. All compounds discussed are research chemicals or investigational compounds unless explicitly noted otherwise. Consult a qualified healthcare professional before making any health-related decisions. Researchers must comply with all applicable laws and regulations in their jurisdiction.
Written by the Peptide Performance Calculator Research Team
Our team compiles research guides based on published literature for educational purposes. All content is for research use only — not medical advice. Read our disclaimer.
Frequently Asked Questions
What is the research dose of tongkat ali extract?
Human clinical trials have predominantly used 200-400mg/day of standardized 100:1 water-soluble Eurycoma longifolia extract. This standardization means 100kg of plant material is processed per kg of extract, ensuring consistent eurycomanone and glycosaponin content. The MIT-developed Physta extract is the most researched standardized form.
How does tongkat ali affect SHBG and free testosterone?
Research suggests Eurycoma longifolia may reduce sex hormone-binding globulin (SHBG) levels, which increases the fraction of testosterone not bound to SHBG (free testosterone). Since only free testosterone is bioactive at androgen receptors, SHBG reduction can meaningfully increase androgenic activity even when total testosterone changes are modest.
How does tongkat ali compare to ashwagandha for testosterone support?
Both herbs increase testosterone in research settings, but via different mechanisms. Tongkat ali primarily works via SHBG reduction and gonadotropin signaling; ashwagandha primarily reduces cortisol (which suppresses HPG axis function) and shows stronger acute stress-reduction effects. They are mechanistically complementary and are often combined in research stacks.
New compound guides and calculator updates — no spam, unsubscribe any time.
Free Peptide Calculators
7 free calculators covering reconstitution, dosage, syringe units, half-life, injection volume, stack planning, and cycle duration — no account needed.